RT Article
T1 Receipt of Pharmacotherapy for Alcohol Use Disorder by Male Justice-Involved U.S. Veterans Health Administration Patients
JF Criminal justice policy review
VO 29
IS 9
SP 875
OP 890
A1 Finlay, Andrea K.
A1 Binswanger, Ingrid
A1 Blue-Howells, Jessica
A1 Clark, Sean
A1 Hagedorn, Hildi
A1 Harris, Alex H. S.
A1 McGuire, Jim
A1 Rosenthal, Joel
A1 Timko, Christine
A1 Van Campen, James
A1 Wong, Jessie
A2 Binswanger, Ingrid
A2 Blue-Howells, Jessica
A2 Clark, Sean
A2 Hagedorn, Hildi
A2 Harris, Alex H. S.
A2 McGuire, Jim
A2 Rosenthal, Joel
A2 Timko, Christine
A2 Van Campen, James
A2 Wong, Jessie
LA English
YR 2018
UL https://krimdok.uni-tuebingen.de/Record/1726241653
AB This study examined whether, among Veterans Health Administration (VHA) patients, veterans with recent or current justice involvement have equal receipt of pharmacotherapy for alcohol use disorder compared with veterans with no justice involvement. Using national VHA records, we calculated the overall and facility rates of receipt as the number of patients who received pharmacotherapy for alcohol use disorder divided by the number of patients diagnosed with an alcohol use disorder. Using a mixed-effects logistic regression model, we tested whether justice involvement was associated with pharmacotherapy receipt. Male veterans with jail/court involvement had significantly higher odds of receiving pharmacotherapy for alcohol use disorder compared with other male veterans. Justice-involved veterans had equal or better receipt of pharmacotherapy for alcohol use disorder compared with veterans with no justice involvement. Pharmacotherapy rates are low overall, suggesting that more work can be done to connect veterans to these medications.
K1 Alcohol-related disorders
K1 Criminal justice
K1 U.S. Department of Veterans Affairs
K1 Naltrexone
K1 Topiramate
DO 10.1177/0887403416644011